|
|
||||||||



*
Center for Dermatology, Department of Medicine, University College London, London, United Kingdom; and
Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, United Kingdom
Langerhans cell (LC) migration from epidermis to draining lymph
node is a critical first step in cutaneous immune responses. Both
TNF-
and IL-1
are important signals governing this process, but
the potential regulatory role of IL-1
processing by caspase-1 is
unknown. In wild-type (WT) mice, application of the contact allergens
2,4-dinitrofluorobenzine and oxazolone lead to a marked reduction in
epidermal LC numbers, but in caspase-1-deficient mice this reduction
was not observed. Moreover, although intradermal injection of TNF-
(50 ng) induced epidermal LC migration in WT mice, this cytokine failed
to induce LC migration in caspase-1-deficient mice. Intradermal IL-1
(50 ng) caused a similar reduction in epidermal LC numbers in both WT
and caspase-1-deficient mice, indicating that, given an appropriate
signal, caspase-1-deficient epidermal LC are capable of migration.
Contact hypersensitivity to both 2,4-dinitrofluorobenzine and oxazolone
was inhibited in caspase-1-deficient mice, indicating a functional
consequence of the LC migration defect. In organ culture the caspase-1
inhibitor Ac-YVAD-cmk, but not control peptide, potently inhibited the
epidermal LC migration that occurs in this system, and reduced
spontaneous migration of LC was observed in skin derived from
caspase-1-deficient mice. Moreover, Ac-YVAD-cmk applied to BALB/c mouse
skin before application of contact sensitizers inhibited LC migration
and contact hypersensitivity in vivo. Taken together, these data
indicate that caspase-1 may play a central role in the regulation of LC
migration and suggest that the activity of this enzyme is amenable to
control by specific inhibitors both in vivo and in
vitro.
This article has been cited by other articles:
![]() |
J.-B. O. Barbaroux, M. Beleut, C. Brisken, C. G. Mueller, and R. W. Groves Epidermal Receptor Activator of NF-{kappa}B Ligand Controls Langerhans Cells Numbers and Proliferation J. Immunol., July 15, 2008; 181(2): 1103 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watanabe, S. Gehrke, E. Contassot, S. Roques, J. Tschopp, P. S. Friedmann, L. E. French, and O. Gaide Danger Signaling through the Inflammasome Acts as a Master Switch between Tolerance and Sensitization J. Immunol., May 1, 2008; 180(9): 5826 - 5832. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Martinon Detection of immune danger signals by NALP3 J. Leukoc. Biol., March 1, 2008; 83(3): 507 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antonopoulos, M. Cumberbatch, J. B. Mee, R. J. Dearman, X.-Q. Wei, F. Y. Liew, I. Kimber, and R. W. Groves IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis J. Leukoc. Biol., February 1, 2008; 83(2): 361 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Miller, E. M. Pietras, L. H. Uricchio, K. Hirano, S. Rao, H. Lin, R. M. O'Connell, Y. Iwakura, A. L. Cheung, G. Cheng, et al. Inflammasome-Mediated Production of IL-1beta Is Required for Neutrophil Recruitment against Staphylococcus aureus In Vivo J. Immunol., November 15, 2007; 179(10): 6933 - 6942. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wannamaker, R. Davies, M. Namchuk, J. Pollard, P. Ford, G. Ku, C. Decker, P. Charifson, P. Weber, U. A. Germann, et al. (S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an Orally Available Selective Interleukin (IL)-Converting Enzyme/Caspase-1 Inhibitor, Exhibits Potent Anti-Inflammatory Activities by Inhibiting the Release of IL-1beta and IL-18 J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Iizasa, H. Yoneyama, N. Mukaida, Y. Katakoka, M. Naito, N. Yoshida, E. Nakashima, and K. Matsushima Exacerbation of Granuloma Formation in IL-1 Receptor Antagonist-Deficient Mice with Impaired Dendritic Cell Maturation Associated with Th2 Cytokine Production J. Immunol., March 15, 2005; 174(6): 3273 - 3280. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. de Noronha, S. Hardy, J. Sinclair, M. P. Blundell, J. Strid, O. Schulz, J. Zwirner, G. E. Jones, D. R. Katz, C. Kinnon, et al. Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein Blood, February 15, 2005; 105(4): 1590 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mohan, M. E. Bruce, and N. A. Mabbott Neuroinvasion by Scrapie following Inoculation via the Skin Is Independent of Migratory Langerhans Cells J. Virol., February 1, 2005; 79(3): 1888 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gervassi, M. R. Alderson, R. Suchland, J. F. Maisonneuve, K. H. Grabstein, and P. Probst Differential Regulation of Inflammatory Cytokine Secretion by Human Dendritic Cells upon Chlamydia trachomatis Infection Infect. Immun., December 1, 2004; 72(12): 7231 - 7239. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Saint-Mezard, C. Chavagnac, S. Bosset, M. Ionescu, E. Peyron, D. Kaiserlian, J.-F. Nicolas, and F. Berard Psychological Stress Exerts an Adjuvant Effect on Skin Dendritic Cell Functions In Vivo J. Immunol., October 15, 2003; 171(8): 4073 - 4080. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wang, C. Feliciani, B. G. Howell, I. Freed, Q. Cai, H. Watanabe, and D. N. Sauder Contribution of Langerhans Cell-Derived IL-18 to Contact Hypersensitivity J. Immunol., April 1, 2002; 168(7): 3303 - 3308. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Reich, A. Heine, S. Hugo, V. Blaschke, P. Middel, A. Kaser, H. Tilg, S. Blaschke, C. Gutgesell, and C. Neumann Engagement of the Fc{epsilon}RI Stimulates the Production of IL-16 in Langerhans Cell-Like Dendritic Cells J. Immunol., December 1, 2001; 167(11): 6321 - 6329. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wang, C. Feliciani, I. Freed, Q. Cai, and D. N. Sauder Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies J. Leukoc. Biol., August 1, 2001; 70(2): 185 - 191. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |